Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-07-17
DOI
10.3389/fphar.2018.00790
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes
- (2018) Miryoung Kim et al. ANNALS OF PHARMACOTHERAPY
- Risk Assessment and Risk Minimization in Nanomedicine: A Need for Predictive, Alternative, and 3Rs Strategies
- (2018) Lisa Accomasso et al. Frontiers in Pharmacology
- The drug delivery field at the inflection point: Time to fight its way out of the egg
- (2017) Kinam Park JOURNAL OF CONTROLLED RELEASE
- Effects of engineered nanoparticles on the innate immune system
- (2017) Yuanchang Liu et al. SEMINARS IN IMMUNOLOGY
- Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies
- (2017) Neda Shajari et al. Current Drug Delivery
- Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy
- (2017) Dinesh Kumar Mishra et al. Drug Delivery and Translational Research
- Recent progress in development of siRNA delivery vehicles for cancer therapy
- (2016) Hyun Jin Kim et al. ADVANCED DRUG DELIVERY REVIEWS
- Dual delivery of biological therapeutics for multimodal and synergistic cancer therapies
- (2016) Bora Jang et al. ADVANCED DRUG DELIVERY REVIEWS
- To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
- (2016) F. Danhier JOURNAL OF CONTROLLED RELEASE
- Comparison of complement activation-related pseudoallergy in miniature and domestic pigs: foundation of a validatable immune toxicity model
- (2016) Joshua A. Jackman et al. Nanomedicine-Nanotechnology Biology and Medicine
- Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
- (2016) Joseph M. Caster et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases
- (2015) Meghna Talekar et al. AAPS Journal
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs
- (2015) Janos Szebeni et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulatory aspects on nanomedicines
- (2015) Vanessa Sainz et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Clinical Translation of Nanomedicine
- (2015) Yuanzeng Min et al. CHEMICAL REVIEWS
- Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
- (2015) Sijumon Kunjachan et al. CHEMICAL REVIEWS
- Quo vadis nanomedicine?
- (2015) Matthias Barz et al. Nanomedicine
- Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue
- (2015) Susan Hua et al. Nanomedicine-Nanotechnology Biology and Medicine
- Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST
- (2015) M. Dusinska et al. Nanotoxicology
- Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques
- (2015) Claudia Calcagno et al. NMR IN BIOMEDICINE
- Defining Nano, Nanotechnology and Nanomedicine: Why Should It Matter?
- (2015) Priya Satalkar et al. SCIENCE AND ENGINEERING ETHICS
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- Nanomedicines: addressing the scientific and regulatory gap
- (2014) Sally Tinkle et al. Annals of the New York Academy of Sciences
- Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls
- (2014) Hideaki Nakamura et al. Expert Opinion on Drug Delivery
- Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect
- (2014) Khaled Greish et al. International Journal of Nanomedicine
- Nanotherapeutics in the EU: an overview on current state and future directions
- (2014) Ivan Pepic et al. International Journal of Nanomedicine
- Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imaging
- (2014) Benjamin Theek et al. JOURNAL OF CONTROLLED RELEASE
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- Quo Vadis Nanomedicine?
- (2014) Robert Luxenhofer et al. Nanomedicine
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications
- (2013) Larissa Y Rizzo et al. CURRENT OPINION IN BIOTECHNOLOGY
- Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders
- (2013) Hamed Laroui et al. DIGESTIVE AND LIVER DISEASE
- Strategies for triggered drug release from tumor targeted liposomes
- (2013) Erik Oude Blenke et al. Expert Opinion on Drug Delivery
- Connecting drug delivery reality to smart materials design
- (2013) David W. Grainger INTERNATIONAL JOURNAL OF PHARMACEUTICS
- SMART drug delivery systems: Back to the future vs. clinical reality
- (2013) Twan Lammers INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
- (2013) Marina A. Dobrovolskaia et al. JOURNAL OF CONTROLLED RELEASE
- Pharmaceutical Development and Regulatory Considerations for Nanoparticles and Nanoparticulate Drug Delivery Systems
- (2013) Ajits. Narang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems
- (2013) John C. Kraft et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Concern-driven integrated approaches to nanomaterial testing and assessment – report of the NanoSafety Cluster Working Group 10
- (2013) Agnes G. Oomen et al. Nanotoxicology
- The use of lipid-based nanocarriers for targeted pain therapies
- (2013) Susan Hua et al. Frontiers in Pharmacology
- Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies
- (2013) Susan Hua Frontiers in Pharmacology
- Challenges in Development of Targeted Liposomal Therapeutics
- (2012) Rupa R. Sawant et al. AAPS Journal
- Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?
- (2012) Roudayna Diab et al. AAPS Journal
- Nanomaterial Toxicity Testing in the 21st Century: Use of a Predictive Toxicological Approach and High-Throughput Screening
- (2012) Andre Nel et al. ACCOUNTS OF CHEMICAL RESEARCH
- Nanotheranostics for personalized medicine
- (2012) Simona Mura et al. ADVANCED DRUG DELIVERY REVIEWS
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
- (2012) Anu Puri et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Clinical translation of nanomedicines
- (2012) Sonke Svenson CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
- Lipid-based carriers: manufacturing and applications for pulmonary route
- (2012) Chiraz Jaafar-Maalej et al. Expert Opinion on Drug Delivery
- Safety assessment of nanomaterials: Implications for nanomedicine
- (2012) Andreas M. Nyström et al. JOURNAL OF CONTROLLED RELEASE
- A new prize system for drug innovation
- (2011) Afschin Gandjour et al. HEALTH POLICY
- Drug targeting systems for inflammatory disease: One for all, all for one
- (2011) Bart J. Crielaard et al. JOURNAL OF CONTROLLED RELEASE
- Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
- (2011) Twan Lammers et al. JOURNAL OF CONTROLLED RELEASE
- Nanotechnology and Nanomedicine: Going Small Means Aiming Big
- (2010) Mahesh Kumar Teli et al. CURRENT PHARMACEUTICAL DESIGN
- From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010
- (2010) David W. Deamer FASEB JOURNAL
- Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation
- (2010) Maria Coimbra et al. JOURNAL OF CONTROLLED RELEASE
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Liposomes targeting tumour stromal cells
- (2010) Sylvia A. Kuijpers et al. MOLECULAR MEMBRANE BIOLOGY
- Polymeric carriers: Preclinical safety and the regulatory implications for design and development of polymer therapeutics
- (2009) Rogério Gaspar et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanomedicine-Challenge and Perspectives
- (2009) Kristina Riehemann et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences
- (2009) Jordan Paradise et al. JOURNAL OF LAW MEDICINE & ETHICS
- Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions
- (2009) Janos Szebeni et al. JOURNAL OF LIPOSOME RESEARCH
- Translational nanomedicine: status assessment and opportunities
- (2009) James S. Murday et al. Nanomedicine-Nanotechnology Biology and Medicine
- Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis
- (2008) Andrei Maiseyeu et al. JOURNAL OF LIPID RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started